![](/img/cover-not-exists.png)
872TiPANZUP 1302: A RANDOMISED PHASE 3 TRIAL OF ACCELERATED VERSUS STANDARD BEP CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE AND POOR-RISK METASTATIC GERM CELL TUMOURS (P3BEP)
Long, A., Toner, G., Stockler, M.R., Thomson, D.B., Gebski, V., Yip, S., King, M., Friedlander, M., Quinn, D.I., Singhal, N., Roncolato, F., Grimison, P.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu337.65
Date:
September, 2014
File:
PDF, 69 KB
2014